摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethyl-N-n-butyl-3-(1-naphthyl)propanamine hydrogen oxalate | 118868-70-5

中文名称
——
中文别名
——
英文名称
N-ethyl-N-n-butyl-3-(1-naphthyl)propanamine hydrogen oxalate
英文别名
N-ethyl-N-(3-naphthalen-1-ylpropyl)butan-1-amine;oxalic acid
N-ethyl-N-n-butyl-3-(1-naphthyl)propanamine hydrogen oxalate化学式
CAS
118868-70-5
化学式
C2H2O4*C19H27N
mdl
——
分子量
359.466
InChiKey
PHBDCUNRLFEAGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.05
  • 重原子数:
    26.0
  • 可旋转键数:
    8.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    77.84
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

反应信息

  • 作为产物:
    描述:
    N-乙基正丁胺 在 palladium on activated charcoal 盐酸氢气 作用下, 以 乙醇异丙醇 为溶剂, 反应 14.0h, 生成 N-ethyl-N-n-butyl-3-(1-naphthyl)propanamine hydrogen oxalate
    参考文献:
    名称:
    Design and synthesis of propranolol analogs as serotonergic agents
    摘要:
    Serotonin (5-HT) binds with nearly identical affinity at the various central 5-HT binding sites. Few agents bind with selectivity for 5-HT1A sites. The beta-adrenergic antagonist propranolol binds stereoselectively both at 5-HT1A and 5-HT1B sites (with a several-fold selectivity for the latter) and, whereas it is a 5-HT1A antagonist, it appears to be a 5-HT1B agonist. As such, it could serve as a lead compound for the development of new 5-HT1A and 5-HT1B agents. The purpose of the present study was to modify the structure of propranolol in such a manner so as to reduce its affinity for 5-HT1B and beta-adrenergic sites while, at the same time, retaining its affinity for 5-HT1A sites. Removal of the side-chain hydroxyl group of propranolol, and conversion of its secondary amine to a tertiary amine, reduced affinity for 5-HT1B and beta-adrenergic sites. In addition, shortening the side chain by one carbon atom resulted in compounds with affinity for hippocampal 5-HT1A sites comparable to that of racemic propranolol, but with a 30- to 500-fold lower affinity for 5-HT1B sites and a greater than 1000-fold lower affinity for beta-adrenergic sites. The results of these preliminary studies attest to the utility of this approach for the development of novel serotonergic agents.
    DOI:
    10.1021/jm00124a021
点击查看最新优质反应信息

文献信息

  • PIERSON, M. EDWARD;LYON, ROBERT A.;TITELER, MILT;KOWALSKI, PAUL;GLENNON, +, J. MED. CHEM., 32,(1989) N, C. 859-863
    作者:PIERSON, M. EDWARD、LYON, ROBERT A.、TITELER, MILT、KOWALSKI, PAUL、GLENNON, +
    DOI:——
    日期:——
查看更多